JUSTIN SIMPSON: Open Payments
NPI 1730891771 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,343 in 391 payments from 35 companies in 2025. Trend: 2023 $5,015 · 2024 $13,573 · 2025 $24,343
Speaker / faculty: $14,776Food & beverage: $7,481Travel & lodging: $2,086
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 54 | $17,741 |
| ABBVIE INC. | 51 | $802 |
| UCB, Inc. | 24 | $573 |
| PFIZER INC. | 35 | $421 |
| Novartis Pharmaceuticals Corporation | 19 | $334 |
| Axsome Therapeutics, Inc. | 16 | $326 |
| Neurocrine BioSciences, Inc. | 15 | $313 |
| SK Life Science, Inc. | 12 | $309 |
| Eisai Inc. | 16 | $300 |
| Lundbeck LLC | 10 | $242 |
Products named: REXULTI, NURTEC ODT, Leqembi, Briviact, KESIMPTA, INGREZZA, BOTOX, Xeomin.
Industry payments across AL — which companies pay providers there.
